Compass PTN Core Measures

Similar documents
Clinical Quality Measures - Colorado SIM, TCPI

Quality Payment Program: Cardiology Specialty Measure Set

Quality Payment Program: Cardiology Specialty Measure Set

2018 MIPS Reporting Family Medicine

DataDerm Quality Measures

CMS-5522-FC TABLE C.1: MIPS Measures Finalized for Removal Only from Specialty Sets for the 2018 Performance Period and Future Years

2016 General Practice/Family Practice Preferred Specialty Measure Set

2016 Internal Medicine Preferred Specialty Measure Set

2016 Cross-Cutting Measure Set

Possible Denominator Codes Applicable to OMS * Le Fort Fractures 21346, 21347, 21348, 21422, 21423, 21432, 21433, 21435, 21436

IQSS 2019 QCDR and MIPS Measure Specifications

2016 Physician Quality Reporting System Data Collection Form: Sinusitis (for patients aged 18 and older)

Practice Director Support

PQRS in TRAKnet 2015 GUIDE TO SUBMIT TING AND REPORTING PQRS IN 2015 THROUGH TRAKNET

PCMH 2018 Enrollment and Update August 25, 2017

The NOF & NBHA Quality Improvement Registry

2016 PQRS Recommended Measures for: General/Family Practice

2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Disease (CAD) (for patients aged 18 and older)

Arkansas Blue Cross and Blue Shield (ABCBS) Patient Centered Medical Home (PCMH) Specifications Manual

The Renal Physicians Association Quality Improvement Registry

emeasure Titles and Descriptions

Oncology Quality Clinical Data Registry

Consensus Core Set: ACO and PCMH / Primary Care Measures Version 1.0

Meaningful Use Clinical Quality Measures for Eligible Professionals

TABLE E: 2017 Finalized MIPS Specialty Measure Sets

2014 Oncology Measures Group Overview

American College of Physicians Genesis Registry

Non-QPP Measures. # Measure Title Definition Type Domain. Cryptorchidism: Inappropriate use of scrotal/groin ultrasound on boys

creatinine lab order placed abdomen, MRI abdomen, ultrasound abdomen ordered or performed

Controlled IOP Uncontrolled IOP Diabetes with or without retinopathy

2016 Physician Quality Reporting System Data Collection Form: Chronic Obstructive Pulmonary Disease (COPD) (for patients aged 18 and older)

Comprehensive ESRD Care (CEC) Model Proposed Quality Measures for Public Comment. Table of Contents

2014 Clinical Quality Measures: Changes for the Medicaid EHR Incentive Program. Tracy McDonald Medicaid EHR Incentive Program Coordinator

CLINICAL QUALITY MEASURES Stage 1 Meaningful Use

Percentage of patients who underwent endoscopic procedures following SWL

Clinical Quality Measures for Submission by Medicare or Medicaid EP/s for the 2011 and 2012 Payment Year

MIPS: Quality Direct EHR Manual for Aprima Users

Non-QPP Measures 3 AQUA12. 6 AQUA15 Stones: Urinalysis documented 30 days before

Clinical Quality Measures

New PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0.

Meaningful Use Simple Guide

NQF Measure Number & PQRI Implementation Number

proposed set to a required subset of 3 to 5 measures based on the availability of electronic

American College of Physicians Genesis Registry

ADDITIONAL INFORMATION REGARDING EP CLINICAL QUALITY MEASURES FOR 2014 EHR INCENTIVE PROGRAMS

2015 PQRS Registry. Source Measure Title Measure Description CITIUS1

2014 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older)

Certified Health IT Transparency and Disclosure Information 2014 Edition

Disease Management. Measures At A Glance

Disease Management. Measures At A Glance

Quality Measures MIPS CV Specific

Meaningful Use for Eligible Providers

The table below includes the quality measures an ACO is required to submit to CMS as a participant in an MSSP Track 3 ACO

For Electronic Measure Specification Information go to:

MEASURING CARE QUALITY

NOA 3rd Party Newsletter PQRS EDITION - Page 1 CONTENTS. Traffic Sheet P.3. Flowsheet & Detailed Directions P.11.

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge.

Individual Quality Measures Applicable to Eligible OMS-MPFS Final Rule 2019

2016 Physician Quality Reporting System Data Collection Form: Total Knee Replacement

OCHSNER PHYSICIAN PARTNERS. PQRS Measures by Specialty (FINAL)

Meaningful Use Criteria for Pediatric Providers

GE Healthcare. Delivering the capabilities you need for Stage 2 in the Ambulatory Setting

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge.

Modified Stage 2 Meaningful Use: Clinical Quality Measures (CQMs) Massachusetts Medicaid EHR Incentive Payment Program

2016 Physician Quality Reporting System Data Collection Form: Sleep Apnea (for patients aged 18 and older)

Table 1. Proposed Measures for Use in Establishing Quality Performance Standards that ACOs Must Meet for Shared Savings

NH State Medicaid HIT Plan

MEASURING CARE QUALITY

Clinical Integration Quality Measures

Meaningful Use Overview

2015 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older)

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name

Consensus Core Set: Cardiovascular Measures Version 1.0

*NOTE: When reporting C P T code and 99239, it is recommended the measure be reported each time the code is submitted for hospital discharge.

Measure Owner Designation. AMA-PCPI is the measure owner. NCQA is the measure owner. QIP/CMS is the measure owner. AMA-NCQA is the measure owner

Measurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI)

2017 MSSP Clinical Quality Measures

SINUSITIS MEASURES GROUP OVERVIEW

Supplementary Appendix

R-SCAN: Engaging Clinicians in Value-based Care

2014 ACO GPRO Audit What this means for your practice. Sheree M. Arnold ACO Clinical Transformation Specialist

MEASURE TYPE. Percentage of female patients aged 65 years and older who were assessed for the presence or absence of urinary incontinence

Practice-Level Executive Summary Report

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

NQF Behavioral Health Project Phase II Submitted Measures

Performance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set

SINUSITIS MEASURES GROUP OVERVIEW

Measure Owner Designation. AMA-PCPI/NCQA (contract) is the measure owner. AMA-PCPI is the measure owner. AMA-PCPI/ASCO/NCCN is the measure owner

May 2016 CTC/OHIC Measure Specifications

MU - Selection & Configuration of Measures

Date Modified: March 31, Clinical Quality Measures for PQRS

2017 HEDIS Measures. PREVENTIVE SCREENING 2017 Measure Quality Indicator

Overview of Current Quality Measures that can be Impacted by Ambulatory Pharmacists

Clinical Quality Measures

PCC EHR Meaningful Use Measures. Maria Horn July 18, :15 pm. Including CQM Reports

NIPM-QCDR Measures for 2019

2017 Eligible Measure Applicability (EMA) for Registry Data Submission of Individual Quality Measures

THERE ARE TWO SUBMISSION CRITERIA FOR THIS MEASURE: 1) Patients who are 18 years and older with a diagnosis of CAD with LVEF < 40%

GUARDIAN CMS QUALIFIED MIPS REGISTRY INFORMATION BRIEF

Transcription:

Compass PTN Core Measures emeasure ID: CMS122v5 NQF: 0059 QualityID: 001 Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) Patients 18-75 years of age with diabetes with a visit during the measurement period. Patients whose most recent HbA1c level (performed during the measurement period) is >9.0%. Effective Clinical Care Intermediate Outcome emeasure ID: CMS165v5 NQF: 0018 QualityID: 236 *This measure is a TCPI Common Measure Controlling High Blood Pressure Patients 18-85 years of age by the end of the measurement year who had at least one outpatient encounter with a diagnosis of hypertension (HTN) during the first six months of the measurement year. The number of patients in the denominator whose most recent BP is adequately controlled during the measurement year. For a patient s BP to be controlled, both the systolic and diastolic BP must be <140/90mmHg (adequate control). To determine if a patient s BP is adequately controlled, the representative BP must be identified. Effective Clinical Care Intermediate Outcome emeasureid: N/A NQF: 1799 QualityID: 444 Medication Management for People with Asthma Patients 5-64 years of age with persistent asthma and a visit during the measure period. The number of patients who achieved a proportion of days (PDC) of at least 75% for their asthma controller medications during the measurement year. emeasure ID: CMS144v5 NQF: 0083 QualityID: 008 Heart Failure (HF): Beta- Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) All patients aged 18 years and older with a diagnosis of heart failure with a current or prior LVEF < 40%. Patients who were prescribed beta-blocker therapy either within a 12 month period when seen in the outpatient setting OR at each hospital discharge. Effective Clinical Care emeasure ID: CMS166v6 NQF: 0052 QualityID: 312 *This measure is a TCPI Common Measure Use of Imaging Studies for Low Back Pain Patients 18-50 years of age with a diagnosis of low back pain during an outpatient or emergency department visit. Patients without an imaging study conducted on the date of the outpatient or emergency department visit or in the 28 days following the outpatient or emergency department visit. Physical emeasure ID: CMS154v4 NQF: 0069 QualityID: 065 Appropriate Treatment for Children with Upper Respiratory Infection (URI) Children age 3 months to 18 years who had an outpatient or emergency department (ED) visit with a diagnosis of upper respiratory infection (URI) during the measurement period. Children without a prescription for antibiotic medication on or 3 days after the outpatient or ED visit for an upper respiratory infection.

QualityID: 419 Overuse of Neuroimaging for Patients with Primary Headache and a Normal Neurological Exam Patients with a diagnosis of primary headache. Patients with a normal neurological examination for whom advanced brain imaging (CTA, CT, MRA, or MRI) was NOT ordered. Overuse of Diagnostic Imaging for Simple Syncope Patients with an outpatient visit (primary care, specialty care, urgent care, etc.) or emergency department visit with a diagnosis for syncope during the measurement period. Patients within denominator population with a CT or MRI ordered within 30 days of visit. Alignment Only QualityID: 415 Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older All emergency department visits for patients aged 18 years and older who presented within 24 hours of a minor blunt head trauma with a Glasgow Coma Scale (GSC) score of 15 and who had a head CT for trauma ordered by an ED provider. Emergency department visits for patients who have an indication for a head CT. Emergency QualityID: 333 Adult Sinusitis: Computerized Tomography (CT) for Acute Sinusitis (Overuse) Patients aged 18 years and older with a diagnosis of acute bacterial sinusitis. Patients who had a CT scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosis. emeasure ID: CMS50v5 QualityID: 374 Closing the Referral Loop: Receipt of Specialist Report Number of patients, regardless of age, who were referred by one provider to another provider, and who had a visit during the measurement period. Number of patients with a referral, for which the referring provider received a report from the provider to whom the patient was referred. Communication and Care Coordination Emergency Physical

emeasure ID: CMS68v6 NQF: 0419 QualityID: 130 Documentation of Current Medications in the Medical Record All visits occurring during the 12 month reporting period for patients aged 18 years and older before the start of the measurement period. Eligible professional attests to documenting, updating or reviewing the patient's current medications using all immediate resources available on the date of the encounter. This list must include ALL known prescriptions, over-the-counters, herbals and vitamin/mineral/dietary (nutritional) supplements AND must contain the medications' name, dosages, frequency and route of administration. Patient Safety Anesthesiology Emergency Physical

TCPI Common Measures *Note: Two of the Compass PTN Measures listed above are TCPI Common Measures TCPI 01 Documentation of a Comprehensive Health and Life Plan Developed Collaboratively by the Patient and the Health Professional Team Total number of patients, of all ages, with two or more chronic conditions in each practice. Number of patients, of all ages, with two or more chronic conditions in each practice for whom a comprehensive health and life plan is documented in the clinical record at each visit. NQS Priority: Strengthen Person and Family Engagement TCPI 02 Referral of At-risk Patients to Community Based Prevention and Support Resources Number of at-risk patients of all ages. Number of at-risk patients, of all ages, referred to local community resources. NQS Priority: Work with communities to promote best practices of healthy living TPCI 03 Medication Management All patients regardless of age. The number of patients, regardless of age, who received medication management services to include the following data: Medications prescribed by any clinician New medications to include: medications the patient has taken previously and are being restarted, medications the patient has not taken before Any changes in medication regimen (change in dose, frequency, duration) Any over the counter medications, vitamins, or herbal preparations Review of allergies, including food-related allergies NQS Priority: Make Care Safer by Reducing Harm, Communication and Coordination of Care emeasure ID: CMS2v6 NQF: 0418 QualityID: 134 Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan All patients aged 12 years and older. Patient s screening for clinical depression using an age appropriate standardized tool AND follow-up plan is documented.

QualityID: 402 NQF: 2597 *Measures in Composite NQF:0028; QualityID: 226 and NQF:2152; QualityID:431 Tobacco Use and Help with Quitting Among Adolescents Substance Use Screening and Intervention Composite All patients aged 12-20 years with a visit during the measurement period. All patients aged 18 years and older who were seen twice for any visits or who had at least one preventive care visit during the 12-month measurement period. Patients who were screened for tobacco use at least once within 18 months (during the measurement period or the six months prior to the measurement period) AND who received tobacco cessation counseling intervention if identified as a tobacco user. Patients who received the following substance use screenings at least once within the last 24 months AND who received an intervention for all positive screening results: Tobacco use component o Patients who were screened for tobacco use at least once within the last 24 months AND who received tobacco cessation intervention if identified as a tobacco user; Unhealthy alcohol use component o Patients who were screened for unhealthy alcohol use using a systematic screening method at least once within the last 24 months AND who received brief counseling if identified as an unhealthy alcohol user; and Drug use component (nonmedical prescription drug use and illicit drug use) o Patients who were screened for nonmedical prescription drug use and illicit drug use at least once within the last 24 months using a systematic screening method AND who received brief counseling if identified as a nonmedical prescription drug user or illicit drug user. Emergency Physical Emergency Physical